DrugRepV_1709 | Pipofezine | Antidepressant | Depressive disorders | Zika virus | MR766 | NA | Cell viability assay | No significant effect (0 %) | NA | 27571349 |
DrugRepV_1780 | Pipofezine | Antidepressant | Depressive disorders | Zika virus | MR766 | NA | Cell viability assay | No significant effect (0 %) | NA | 27571349 |
DrugRepV_1851 | Pipofezine | Antidepressant | Depressive disorders | Zika virus | MR766 | NA | Cell viability assay | No significant effect (0 %) | NA | 27571349 |
DrugRepV_2752 | Rolipram | Antidepressant | Depressive disorder | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-3.9578731 %) | Experimental | 27742486 |
DrugRepV_2857 | Rolipram | Antidepressant | Depressive disorder | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-6.8983502 %) | Approved | 27742486 |